PCVX in the 13F filings
Vaxcyte Inc · CUSIP 92243G108
- Quarter end
- 31 Mar 2026
- the date the book describes
- Filed
- 27 Oct 2026
- latest of these filings; the earliest 12 May 2026
- Managers listing it
- 30
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q4 2025 and Q1 2026; 9 listed it in both
- Shares listed
- 50,171,892
- combined, among listed positions
- Reported value
- $2.9bn
- combined, at the quarter end
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 18 buyers (opened or added shares) and 13 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +7,527,139.
Managers listing PCVX in Q1 2026
30 of 30 holders
Largest increases and reductions, by shares
Increases
- Janus Henderson Group Ltdexisting position · 16,575,875 shares now+3,188,687
- Fidelity (FMR LLC)existing position · 16,492,861 shares now+2,658,347
- Farallon Capital Management LLCexisting position · 1,261,000 shares now+1,256,000
- Baupost Group LLCnew position · 800,000 shares now+800,000
- Balyasny Asset Management LLCexisting position · 514,577 shares now+487,712
Reductions
- D. E. Shaw & Co.existing position · 2,865,318 shares now-765,735
- Wellington Management Group LLPexisting position · 5,614,597 shares now-351,713
- T. Rowe Price Associates Incexisting position · 976,429 shares now-198,910
- Millennium Management LLCexisting position · 293,695 shares now-130,599
- Man Group PLCexisting position · 19,257 shares now-49,656
New positions and exits
New (5)
Exited (3)
- Citadel Advisors LLCwas $15m
- Verition Fund Management LLCwas $726k
- Quantbot Technologies LPwas $249k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2020 | 2 | $141m | n.a. | n.a. |
| Q3 2020 | 2 | $515m | n.a. | n.a. |
| Q4 2020 | 1 | $108m | n.a. | n.a. |
| Q1 2021 | 1 | $84m | n.a. | n.a. |
| Q2 2021 | 1 | $93m | n.a. | n.a. |
| Q3 2021 | 1 | $104m | n.a. | n.a. |
| Q4 2021 | 2 | $103m | n.a. | n.a. |
| Q1 2022 | 2 | $106m | n.a. | n.a. |
| Q2 2022 | 4 | $107m | n.a. | n.a. |
| Q3 2022 | 5 | $140m | n.a. | n.a. |
| Q4 2022 | 12 | $1.2bn | n.a. | n.a. |
| Q1 2023 | 8 | $978m | n.a. | n.a. |
| Q2 2023 | 8 | $1.6bn | n.a. | n.a. |
| Q3 2023 | 9 | $1.8bn | n.a. | n.a. |
| Q4 2023 | 9 | $2.1bn | 5 | 4 |
| Q1 2024 | 9 | $2.7bn | 8 | 1 |
| Q2 2024 | 10 | $3.1bn | 4 | 6 |
| Q3 2024 | 12 | $5.1bn | 8 | 4 |
| Q4 2024 | 11 | $3.6bn | 6 | 6 |
| Q1 2025 | 6 | $1.8bn | 3 | 3 |
| Q2 2025 | 7 | $969m | 5 | 2 |
| Q3 2025 | 9 | $940m | 5 | 5 |
| Q4 2025 | 9 | $1.8bn | 13 | 18 |
| Q1 2026 | 12 | $2.7bn | 18 | 13 |
| Q2 2026 | 8 | $2.9bn | 13 | 17 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
PCVX and GILD →PCVX and AMGN →PCVX and ARGX →Choose a stock to compare with PCVX →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own PCVX, latest filings →Back to the 13F Explorer →